Utility of polymerase chain reaction for analysis of antigen receptor rearrangement in staging and predicting prognosis in dogs with lymphoma

Journal of Veterinary Internal Medicine

Volumn 20, Issue 2, 2006, Pages 329-334

  Lana, Susan E ^a   Jackson, Tracey L ^a   Burnett, Robert C ^a   Morley, Paul S ^a   Avery, Anne C ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

B cell; Clonality; Hematologic malignancy; T cell

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETICS; IMMUNOLOGY; LYMPHOMA; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS;

ANIMALS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; LYMPHOMA; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, ANTIGEN;

CANIS FAMILIARIS;

EID: 33645576655     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[329:UOPCRF]2.0.CO;2     Document Type: Article

References (19)

1. Morley A. Quantifying leukemia. N Engl J Med 1998;339:627-629.
2. Raulet DH. The structure, function, and molecular genetics of the γ/δ T cell receptor. Annu Rev Immunol 1989;7:175-207.
3. Schatz DG, Oettinger MA, Schlissel MS. V(D)J recombination: Molecular biology and regulation. Annu Rev Immunol 1992;10:359-383.
4. Burnett RC, Vernau W, Modiano JF, et al. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet Pathol 2003;40:32-41.
5. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-2317.
6. Swerdlow SH. Genetic and molecular genetic studies in the diagnosis of atypical lymphoid hyperplasias versus lymphoma. Hum Pathol 2003;34:346-351.
7. Langerak AW, van Krieken JHJM, Wolvers-Tettero ILM, et al. The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders. J Clin Pathol 2001;54:565-567.
8. Cave H, van der Werff ten Bosch J, Suciu S, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. N Engl J Med 1998;339:591-598.
9. van Belzen N, Hupkes PE, Doekharan D, et al. Detection of minimal residual disease using rearranged immunoglobulin heavy chain genes from intermediate and high grade malignant B cell non-Hodgkin's lymphoma. Leukemia 1997;11:1742-1752.
10. Leal E, Esparza-Flores MA, Lopez-Guido B, et al. Detection and monitoring of clonality in peripheral blood and bone marrow of patients with B-cell lymphoproliferative disorders. Hematol Oncol 2003;21:25-31.
11. Muche JM, Lukowsky A, Asadulluh K, et al. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood 1997;90:1636-1642.
12. Vail DM, MacEwen EG, Young KM. Canine lymphoma and lymphoid leukemias. In: Withrow SJ, MacEwen EC, eds. Small Animal Clinical Oncology, 3rd ed. Philedelphia, PA: WB Saunders; 2001:558-590.
13. Keller RL, Avery AC, Burnett RC, et al. Detection of neoplastic lymphocytes in peripheral blood of dogs with lymphoma by polymerase chain reaction for antigen receptor gene rearrangement. Vet Clin Path 2004;33:145-149.
14. Mitterbauer-Hohendanner G, Mannhalter C, Winkler K, et al. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangement in diffuse large B-cell lymphoma (DLBCL). Leukemia 2004;18:1102-1107.
15. Modiano JF, Burnett RC, Parker HG, et al. Distinct B cell and T cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. Cancer Res 2005;65:5654-5661.
16. Ruslander DA, Gebhard DH, Tompkins MB, et al. Immunophenotypic characterization of canine lymphoproliferative disorders. In Vivo 1997;11:169-172.
17. Greenlee PG, Filippa DA, Quimby FW, et al. Lymphomas in dogs. Cancer 1990;66:480-490.
18. Teske E, van Heerde P, Rutteman GR, et al. Prognostic factors for treatment of malignant lymphoma in dogs. J Am Vet Med Assoc 1994;205:1722-1728.
19. Ponce F, Mangol JP, Ledieu D, et al. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Vet J 2004;167:158-166.